Ansley Alberts, PA
Medical · Lincoln, NENPI 1982355707
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Sanofi at 39.5% of the total.
Across 72 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$601
- Regeneron Healthcare Solutions, Inc.$374
- Dexcom, Inc.$110
- Ascendis Pharma Endocrinology Inc$73
- Pharming Healthcare, Inc.$69
- Optinose US, Inc.$48
- plus $246 from 10 others
What the payments were for
- Food & beverage$1,522100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 33 | $601 |
| Regeneron Healthcare Solutions, Inc. | 15 | $374 |
| Dexcom, Inc. | 2 | $110 |
| Ascendis Pharma Endocrinology Inc | 2 | $73 |
| Pharming Healthcare, Inc. | 3 | $69 |
| Optinose US, Inc. | 3 | $48 |
| Inspire Medical Systems, Inc. | 3 | $45 |
| Insulet Corporation | 1 | $38 |
| Integra Lifesciences Corporation | 2 | $38 |
| Acclarent, Inc | 2 | $34 |
| Medtronic | 1 | $18 |
| AbbVie | 1 | $17 |
| Stryker | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Merck | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,522 in reported general payments places this provider in the 75th percentile of 216 medical providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 14 | $437 |
| Montelukast Sodium | 53 | $423 |
| Ipratropium Bromide | 20 | $399 |
| Ofloxacin | 22 | $353 |
| Pantoprazole Sodium | 23 | $301 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $300 |
| Doxycycline Hyclate | 24 | $275 |
| Omeprazole | 16 | $94 |
| Prednisone | 19 | $43 |
Paid to pharmacies, not to this prescriber.
Other medical in Lincoln
- Michelle SitzmanLincoln$206K
- Kaitlin MatthesLincoln$98K
- Jay ArthurLincoln$8K
- Emma EdwardsLincoln$8K
- Erin HeggeLincoln$7K
- Christine TrombinoLincoln$5K
- Samantha PedersonLincoln$5K
- Sheri JohnsonLincoln$5K
- Kerri OttoLincoln$5K
- Mason BeelLincoln$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.